4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-21-020536
Chief Executive Officer bought 5,000 shares at $3.00 ($15,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2021-08-17 | Purchase | +5,000 | $3.00 | $15,000 | 10,500 | D |
| Open-market purchases · 5,000 sh · avg $3.00 · $15,000 | |||||||
Loading xslF345X03/ownership.xml…